Enbrel paediatric psoriasis indication hits US delay
This article was originally published in Scrip
Executive Summary
Amgenand Wyeth's attempt to add a paediatric psoriasis indication for the TNF-inhibitor Enbrel (etanercept) have hit a delay in the US.